Impact of Revascularization Completeness on Outcomes of Patients with Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement

References

• Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol. July 1, 1988;62:117–400.
   PubMed Web of Science ®Google Scholar
• Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol. 1997 March 1;29:630–634.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Conrotto F, Giordana F, et al. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. Int J Cardiol. October 3 2013;168:2528–2532. doi:10.1016/j.ijcard.2013.03.062.
   Web of Science ®Google Scholar
• Tjang YS, van Hees Y, Korfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur J Cardiothorac Surg. September 2007;32:469–474. doi:10.1016/j.ejcts.2007.06.012.
   Web of Science ®Google Scholar
• Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. September 1990;100:327–337.
   PubMed Web of Science ®Google Scholar
• Mullany CJ, Elveback LR, Frye RL, et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol. July 1987;10:66–72.
   Web of Science ®Google Scholar
• Thalji NM, Suri RM, Daly RC, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. February 2015;149:451–460. doi:10.1016/j.jtcvs.2014.08.073.
   Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. June 10 2014;129:2440–2492. doi:10.1161/CIR.0000000000000029.
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American Heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation. August 1 2006;114:e84–231. doi:10.1161/CIRCULATIONAHA.106.176857.
   PubMed Web of Science ®Google Scholar
• Kotronias RA, Kwok CS, George S, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017 June 27;6. doi:10.1161/JAHA.117.005960.
   Web of Science ®Google Scholar
• Van Mieghem NM, van der Boon RM, Faqiri E, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv. August 2013;6:867–875. doi:10.1016/j.jcin.2013.04.015.
   PubMed Web of Science ®Google Scholar
• Shamekhi J, Stundl A, Weber M, et al. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. Int J Cardiol. October 15 2017;245:215–221. doi:10.1016/j.ijcard.2017.07.082.
   PubMed Web of Science ®Google Scholar
• Sankaramangalam K, Banerjee K, Kandregula K, et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis. J Am Heart Assoc. 2017 October 11;6. doi:10.1161/JAHA.117.006092.
   Web of Science ®Google Scholar
• Farooq V, Head SJ, Kappetein AP, Serruys PW. Widening clinical applications of the SYNTAX score. Heart. February 2014;100:276–287. doi:10.1136/heartjnl-2013-304273.
   Web of Science ®Google Scholar
• Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. March 5 2009;360:961–972. doi:10.1056/NEJMoa0804626.
   PubMed Web of Science ®Google Scholar
• Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. July 9 2013;128:141–151. doi:10.1161/CIRCULATIONAHA.113.001803.
   PubMed Web of Science ®Google Scholar
• Genereux P, Campos CM, Yadav M, et al. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX revascularisation index. EuroIntervention. October 2015;11:634–642. doi:10.4244/EIJY14M10_05.
   Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. November 2012;42:S45–60. doi:10.1093/ejcts/ezs533.
   PubMed Web of Science ®Google Scholar
• Wolff G, Dimitroulis D, Andreotti F, et al. Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis. Circ Heart Fail. 2017 January;10. doi:10.1161/CIRCHEARTFAILURE.116.003255.
   Web of Science ®Google Scholar
• Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous coronary intervention versus transcatheter aortic valve replacement alone in the United States. Am J Cardiol. December 1 2016;118:1698–1704. doi:10.1016/j.amjcard.2016.08.048.
   Web of Science ®Google Scholar
• Witberg G, Zusman O, Codner P, Assali A, Kornowski R. Impact of coronary artery revascularization completeness on outcomes of patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis of studies using the residual SYNTAX score (Synergy Between PCI With Taxus and Cardiac Surgery). Circ Cardiovasc Interv. March 2018;11:e006000. doi:10.1161/CIRCINTERVENTIONS.118.006388.
   Web of Science ®Google Scholar
• Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. July 24 2017;10:1428–1435. doi:10.1016/j.jcin.2017.04.035.
   PubMed Web of Science ®Google Scholar
• Paradis JM, White JM, Genereux P, et al. Impact of coronary artery disease severity assessed with the SYNTAX score on outcomes following transcatheter aortic valve replacement. J Am Heart Assoc. 2017 February 20;6. doi:10.1161/JAHA.116.005070.
   Web of Science ®Google Scholar
• Khawaja MZ, Asrress KN, Haran H, et al. The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the edwards bioprosthesis. EuroIntervention. August 2015;11:450–455. doi:10.4244/EIJY14M05_09.
   PubMed Web of Science ®Google Scholar
• Stefanini GG, Stortecky S, Cao D, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J. October 1 2014;35:2530–2540. doi:10.1093/eurheartj/ehu074.
   PubMed Web of Science ®Google Scholar
• Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol. October 15 2013;62:1421–1431. doi:10.1016/j.jacc.2013.05.033.
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. March 11 2008;117:1283–1291. doi:10.1161/CIRCULATIONAHA.107.743963.
   PubMed Web of Science ®Google Scholar
• Ahn JM, Park DW, Lee CW, et al. Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials. JACC Cardiovasc Interv. July 24 2017;10:1415–1424. doi:10.1016/j.jcin.2017.04.037.
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018 August 25. doi:10.1093/eurheartj/ehy658.
   Web of Science ®Google Scholar